36827-98-2Relevant articles and documents
An efficient and practical method for the synthesis of the 5-acylamino-4-(4-pyrimidinyl)isoxazole derivative AKP-001, a potent P38 map kinase inhibitor
Ohta, Shuji,Saito, Takahisa,Kato, Jun-Ya,Sato, Shuichiro,Hayashi, Hiroyuki,Hasumi, Koichi
, p. 938 - 948 (2017/06/13)
5-Acylamino-4-(4-pyrimidinyl)isoxazole derivative AKP-001 is a p38 mitogen-activated protein kinase inhibitor previously developed in our laboratory as an anti-inflammatory agent. Herein, we report our studies leading to the development of an improved syn
Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors
Stevens, Kirk L.,Jung, David K.,Alberti, Michael J.,Badiang, Jennifer G.,Peckham, Gregory E.,Veal, Jim M.,Cheung, Mui,Harris, Philip A.,Chamberlain, Stanley D.,Peel, Michael R.
, p. 4753 - 4756 (2007/10/03)
(Chemical Equation Presented) A convergent synthesis of substituted pyrazolo[1,5-a]pyridines has been achieved either via a regioselective [3 + 2] cycloaddition of N-aminopyridines with alkynes or by thermal cyclization of disubstituted azirines. Subseque
Fused pyrazole derivatives bieng protein kinase inhibitors
-
, (2008/06/13)
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, (R2, and R4 are various substituent groups, are protein kinase inhibitors.